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The Epithelial to Mesenchymal Transition (EMT) regulates cell plasticity during embryonic
development and in disease. It is dynamically orchestrated by transcription factors (EMT-
TFs), including Snail, Zeb, Twist and Prrx, all activated by TGF-β among other signals. Here
we find that Snail1 and Prrx1, which respectively associate with gain or loss of stem-like
properties and with bad or good prognosis in cancer patients, are expressed in com-
plementary patterns during vertebrate development and in cancer. We show that this
complementarity is established through a feedback loop in which Snail1 directly represses
Prrx1, and Prrx1, through direct activation of the miR-15 family, attenuates the expression of
Snail1. We also describe how this gene regulatory network can establish a hierarchical
temporal expression of Snail1 and Prrx1 during EMT and validate its existence in vitro and
in vivo, providing a mechanism to switch and select different EMT programs with important
implications in development and disease.
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The epithelial to mesenchymal transition (EMT) is adevelopmental process that can be ectopically reactivatedin diseases like cancer. When they undergo EMT, epithelial
immotile cells become mesenchymal, acquiring the ability to
migrate and invade1. During tumor progression, EMT provides
invasive and migratory properties to cancer cells1–4. This phe-
notypic transition is governed by extracellular signals that activate
a plethora of EMT transcription factors (EMT-TFs) that include
those belonging to the Snail, Zeb, Twist, and Prrx families1.
Different mesenchymal cells of embryonic, healthy adult or
pathological origin, express different combinations of EMT-TFs,
leading to a tissue-specific EMT-TF code5, which may influence
the overall state, function, and behavior of the cell. In addition to
the transition toward the mesenchymal phenotypes, Snail1,
Twist1, and Zeb1 can also induce stemness6,7, while Prrx1
expression is concomitant with the loss of stemness8,9. In cancer,
highSnail1 expression is associated with malignant phenotype
and poor prognosis10,11, while the high expression of Prrx1 is
associated with good prognosis and metastasis-free disease8. In
the chicken embryo, PRRX1 and SNAIL1 are expressed in a
complementary manner8 and in breast cancer Prrx1 expression
correlates with that of Twist1 but not Snail18. These differences
can be considered as different EMT modes associated with the
dominant EMT-TF in a given cellular context5. Studying the
differences between all these EMT-TFs is important to under-
stand cell plasticity during embryonic development, which can
ultimately help to distinguish the key altered cellular and mole-
cular mechanisms in disease.
Combined expression of SNAIL1 and PRRX1 covers almost the
entire mesenchymal cell population in the chicken embryo8.
Although there are clear differences in the EMT activated by each
factor in development and cancer, the two are activated by the
same extracellular signals, the transforming growth factor
beta (TGF-β) superfamily8,12. Therefore, we want to assess
whether there is a crosstalk between Snail1 and Prrx1, by which
each factor promotes its own EMT mode, particularly by differ-
ential regulation of stemness.
Here, we describe a gene regulatory network (GRN) by which
Snail1 directly represses Prrx1 transcription, and Prrx1, through
direct activation of the miR-15 family, attenuates Snail1 expres-
sion. We find that Snail1 is a direct target of these microRNAs
(miRNAs) among different vertebrate species. miRNAs are short
noncoding RNAs that posttranscriptionally regulate their target
genes13, and are crucial players in regulating cell plasticity and
EMT14. We also find that this GRN triggers an expression switch
from Snail1 to Prrx1, with Snail1 being an early response gene to
EMT-inducing signals, followed by the activation of Prrx1 that in
turn attenuates Snail1 expression. We support our findings by
analyses in cultured cells, in vivo in different vertebrate embryos
and public databases of cancer patients. We illustrate that this
GRN rather than regulating the balance between epithelial and
mesenchymal states as the previously described networks invol-
ving microRNAs, drives the selection of the EMT mode.
Results
Prrx1 and Snail1 are expressed in complementary patterns. In
zebrafish embryos, which bear two paralogs for each gene (prrx1a
and prrx1b; snail1a and snail1b) due to the extra duplication in
the teleost genome3,15, we performed RNA in situ hybridization
(ISH) and found a complementary expression pattern. In the
developing somites where snail genes are abundantly expressed,
prrx1 genes expression are restricted to small cell populations
where snail expression is low or absent (Fig. 1a). Although at 20-
somite stage both snail1 and prrx1 are expressed in the cranial
neural crest (Fig. 1a), transverse sections of double-fluorescent
ISH shows that they are also expressed in a complementary
manner (Fig. 1b). Single-cell RNA sequencing (scRNA-seq) data
from zebrafish embryos at 18 h post fertilization (hpf) (GEO:
GSM3067194)16 provides further evidence for this com-
plementary expression of snail1a/b and prrx1a/b in the majority
of cells, with a significant negative correlation (Fig. 1c, Supple-
mentary Fig. 1a). This is compatible with our previous findings in
the chicken embryo8 (Fig. 1d).
To assess whether this complementarity was also conserved in
mammals, we characterized the expression of Snail1 and Prrx1 in
the mouse. At E8.5, embryos manifest a complementary
expression pattern for Snail1 and Prrx1 at whole-mount level,
particularly evident in the mesodermal populations along the
medio-lateral axis and in the somites (Fig. 1e). Transverse
sections of anterior regions (Fig. 1e) confirm this complementar-
ity in the neural crest populations, where Snail1 is expressed in
the premigratory crest (arrow) and both are expressed in
migratory neural crest populations (arrowheads) in a distinct
manner. In more posterior tissues (Figs. 1e and dashed line2), the
complementarity is evident in the mesodermal cells, where Snail1
is highly expressed in the pre-somitic mesoderm (arrow) while
Prrx1 is expressed in the lateral plate mesoderm (LPM, arrow-
head). Expression is also complementary at E9.5 mouse embryos
in the somites and as in the chick, Snail1 is highly expressed in
immature somites where Prrx1 expression is not evident. Also,
LPM cells are positive for Prrx1 expression but not Snail1
(Supplementary Fig. 1b). Analysis of transverse sections at the
level of the branchial arches, also showed complementarity, where
in more internal cell populations Snail1 was highly expressed
concomitant with low Prrx1 expression, while more ventral cell
populations showed high expression of Prrx1 and lower of Snail1
(Supplementary Fig. 1c). A similarly complementary pattern was
also evident in the mature somites. Snail1 is highly expressed in
the sclerotome (SC) and Prrx1 in the dermomyotome (DM)
(Supplementary Fig. 1d). The analysis of scRNA-seq from E9.5
embryos (GEO: GSE87038)17 clearly shows this complementary
expression at the single-cell level (Fig. 1f). These data confirm
that Snail1 and Prrx1 are expressed in a conserved dynamic and
complementary manner in cells undergoing EMT during
vertebrate development.
To determine whether this complementary expression pattern
holds true in pathology, we first looked at the expression levels of
SNAIL1 and PRRX1 in human breast cancer cell lines18, and did
not find cells with both SNAIL1 and PRRX1 high. Supplementary
Figure 1e shows examples of cell lines with high-SNAIL1
expression (SUM149PT); cells with intermediate/low levels of
both (MDA436), and cells with high-PRRX1 expression (BT549).
These three cell lines are derived from triple-negative/basal type
breast tumors, and manifest mesenchymal properties19, including
migratory and invasive behaviors8,20. However, SUM149PT and
MDA436 cells are metastatic and show cancer stem cell-like
properties21, while BT549 cells need to lose PRRX1 expression to
acquire both stem cell properties and metastatic potential8. Thus,
the comparison of the three cell lines for SNAIL1 and PRRX1
expression can provide insights into their potential regulation.
Signal intensity analyses for SNAIL1 and PRRX1 proteins show a
negative correlation in SUM149PT and BT549. Interestingly,
MDA436 expresses both SNAIL1 and PRRX1 at similar
intermediate levels (Supplementary Fig. 1f), altogether suggesting
that SNAIL1 or PRRX1 cannot be co-expressed at high levels.
Next, we examined databases from breast cancer patients
(GEO: GSE75688)22, and found that SNAIL1 and PRRX1 depict a
complementary expression pattern with a significant negative
correlation (Fig. 1g). In addition, in a larger scRNA-seq dataset
from head and neck carcinoma patients (GEO: GSE103322)23,
SNAIL1 and PRRX1 expressions were also complementary and
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2 NATURE COMMUNICATIONS |         (2019) 10:5115 | https://doi.org/10.1038/s41467-019-13091-8 | www.nature.com/naturecommunications
negatively correlated, with some small cell populations expressing
both (Fig. 1h). Notably, in all the analyzed scRNA-seq datasets,
extremely few cells were found to express both EMT-TFs at high
levels (Supplementary Table 1).
Taken together, these findings suggest that there may be a
regulatory mechanism between these two EMT-TFs that is
conserved not only during vertebrate development but also in
pathological EMTs. Therefore, we next wanted to understand the
molecular basis of the complementary expression of Snail1 and
Prrx1. Considering that they are TF and there have been previous
examples of mutually regulated TF pairs during embryonic
development24,25, we set up to study this possibility for Snail1 and
Prrx1. To test this hypothesis, we first examined the response in
terms of gene expression after acute downregulation of either
SNAIL1 or PRRX1 in the same cell context. We used MDA436
cells, which express both TFs at low/intermediate levels, and
found that SNAIL1 knockdown (KD) using short interfering
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Fig. 1 Snail1 and Prrx1 complementary expression in development and disease. a Lateral view of 20-somite zebrafish embryos showing snail1a, snail1b, prrx1a
and prrx1b expression in whole-mount (top) and transverse sections (1), showing complementary patterns in somites. b Transverse section of a zebrafish
embryo in the cranial neural crest region showing complementary expression of snail1a/b (green) and prrx1a/b (red) taken at the level indicated by (2) in
(a) with or without DAPI staining (nuclei). c Heatmap showing hierarchical clustering of scRNA-seq data from 18 hpf zebrafish embryos, from public
database GEO: GSM3067194, with significant negative correlations between gene pairs (detailed in Supplementary Fig. 1a). d Dorsal view of HH10 chicken
embryos showing PRRX1 and SNAIL1 expression in whole-mount and transverse sections at the level indicated by dashed lines, showing complementary
patterns for SNAIL1 and PRRX1 In the somites (arrow) and in the LPM (splanchnopleura and somatopleura, respectively; arrowheads). e Expression of Snail1
and Prrx1 in dorsal views of E8.5 mouse embryos. Transverse sections of E8.5 embryos from the regions indicated by dashed lines (anterior and posterior, 1
and 2, respectively), showing complementary expression of Snail1 and Prrx1 in premigratory (1, arrow), and migratory (1, arrowheads) neural crest (PNC and
MNC, respectively) and mesodermal populations including presomitic mesoderm (2, arrow) and lateral plate mesoderm (2, arrowhead). f Hierarchical
clustering heatmaps of scRNA-seq data from E9,5 mouse embryos for Snail1 and Prrx1 expression (GEO: GSE87038), showing a significant negative
correlation. This dataset contains cells from different embryonic tissues, shown in different colors. g, h Heatmaps of hierarchical clusterings of single-cell
RNA sequencing data from public datasets of breast (GEO: GSE75688) and head and neck carcinoma (GEO: GSE103322), showing mutually exclusive
expression of Snail1 and Prrx1. The color scale shown in (f) is also valid for (g) and (h), representing the normalized values for the number of reads. Scale
bars: 250 μm for whole mounts and 100 μm for sections. Statistical analyses for scRNA-seq data has been done using Spearman r correlation test, scRNA-
seq single-cell RNA sequencing, vs. versus, hpf hours post fertilization. Source data are provided as a Source Data file
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similarly, PRRX1 KD resulted in SNAIL1 upregulation (Supple-
mentary Fig. 1g). These observations prompted us to investigate
the molecular relationship between Snail1 and Prrx1.
Snail1 directly represses Prrx1. As Snail1 has been described as a
potent transcriptional repressor26, we examined whether it could
directly target Prrx1 transcription. We looked for consensus
Snail1 E-boxes27 within the mouse and human Prrx1 promoters
and putative enhancer regions, and found several predicted
binding sites (BS). To narrow down the number of BSs we used
ENCODE data from different cell contexts28 using UCSC genome
browser (https://genome-euro.ucsc.edu/index.html), and focused
on the regions that were conserved and positive for DNase-I
hypersensitivity and H3K27Ac marks, suggesting an active
chromatin region. We performed chromatin immunoprecipita-
tion (ChIP) assay in NIH3T3 mouse fibroblast cells transiently
overexpressing Snail1, and found several regions with significant
enrichment for Snail1 protein occupancy in the mouse Prrx1
promoter; BS1–3 (Supplementary Fig. 2a), which results in
repression of promoter activity showed using dual luciferase
reporter assay (Supplementary Fig. 2b). We then analyzed the
human PRRX1 promoter and performed ChIP in BT549 cells
transiently overexpressing Snail1, and found at least two sites
with significant enrichment for its protein occupancy, BS1–2
(Fig. 2a). Snail1 binding leads to repression of the promoter
activity, which is abolished upon deletion of BS2 (Fig. 2b). In
agreement with this, PRRX1 was downregulated after SNAIL1
transfection in BT549 (Fig. 2c). Altogether, these results indicate
that Snail1 directly binds to, and represses Prrx1 promoter
activity both in mouse and human cells.
Prrx1 induces its own expression. When we searched for Snail1
E-boxes in both mouse and human Prrx1 promoters, we also
found several predicted Prrx1 BSs (TAATKDS)29 (Fig. 2d and
Supplementary Fig. 2c). Thus, we next examined whether Prrx1
could regulate its own transcription. We used above-mentioned
strategy to narrow down the potential BSs. We performed ChIP
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Fig. 2 SNAIL1 and PRRX1 act antagonistically on PRRX1 promoter. a Snail1 enrichment in the human PRRX1 promoter shown by ChIP assay in BT549 cells,
using anti Myc antibody (for Snail1-Myc overexpression). A schematic map is shown; red diamonds represent SNAIL1 potential binding sites (E-boxes;
CANNTG) on PRRX1 promoter. (BS1: –1689, BS2: −4102, BS3: −6753, BS4: −7277, BS5: −7318 and NC: +104560). Ex1: PRRX1 exon 1 (n= 4). b Activity of
different regions of the human PRRX1 promoter after SNAIL1 transfection assessed by luciferase assays in HEK293 cells (n= 4, except for BS1–5 for which
n= 8). c qPCR assay showing downregulation of PRRX1 transcription upon SNAIL1 transfection in BT549 cells (n= 4). d PRRX1 directly binds to its own
promoter, as assessed by ChIP assays in BT549 cells using a PRRX1 specific antibody. A schematic map is shown; cyan diamonds represent PRRX1
potential binding sites (TAATKDS) on its own promoter. (BS7: −6875, BS6: −5579, BS5: −5202, BS4: −4147, BS3: −4096, BS2: −1653, BS1: −1197 and
NC: +104560). Ex1: PRRX1 exon 1 (n= 6, except for BS1–2 for which n= 4). e Activity of different regions of the human PRRX1 promoter after PRRX1
overexpression in luciferase assays in HEK293 cells (n= 4). f Lack of enrichment for PRRX1 binding to human SNAIL1 promoter assessed by ChIP assays in
BT549 cells (BS4–1: −1753, −1621, −954, −198, and NC: +11799). Ex1: SNAIL1 exon 1 (n= 4). Locations of red and cyan diamonds represent distances
between BSs and the promoter. Arrows represent primers used for qPCR amplification. BS biding site, NC negative control region, which does not contain
potential BSs. Symbols in binding sites are as follows. K: T/G, D: G/A/T, S: G/C and N: G/A/T/C. Bars represent mean plus standard error of the mean
(SEM), indicated (n) represent number of independent experiments as biological replicates and asterisks indicate significant p value in t test compared to
the control in each test for (a), (e), (d), (f) and ANOVA with Bonferroni’s multiple comparison test for (b), (e) (*p < 0.05, **p < 0.01 and ***p < 0.001).
Source data are provided as a Source Data file
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found two regions with enrichment for Prrx1 occupancy in its
own promoter (BS3–4, Supplementary Fig. 2c). In human BT549
cells, endogenous PRRX1 protein occupancy was significantly
enriched in several BS (Fig. 2d). Luciferase assay for both mouse
and human sequences show an activation of the Prrx1 promoter
upon Prrx1 overexpression (Fig. 2e and Supplementary Fig. 2d)
and this activation no longer occurs when BS7 is deleted (Fig. 2e).
Next, we wanted to know whether there was a reciprocal
regulation between Snail1 and Prrx1, and we examined Prrx1
protein binding in the Snail1 promoter. Although we found
putative Prrx1 BSs within the Snail1 proximal promoter that met
our criteria, ChIP in both mouse (Supplementary Fig. 2e) and
human cells (Fig. 2f) failed to show Prrx1 protein binding
enrichment in those sites. In addition, activity assay for Snail1
promoter shows no significant change when Prrx1 is over-
expressed (Supplementary Fig. 2f). Altogether, these results
indicate that Prrx1 is able to bind to its own promoter and
enhance its own expression, but it does not bind to Snail1
promoter, suggesting that Prrx1 is not a direct Snail1 transcrip-
tional repressor. In fact, Prrx1 has been described as a
transcriptional activator30, which suggests a putative indirect
regulation of Snail1 expression by Prrx1.
Prrx1 directly induces expression of miR-15 family members.
To investigate downstream targets of PRRX1, we used MDA-MB-
231 breast cancer cells which express low level of PRRX1 to
generate a stable cell line where PRRX1 was ectopically over-
expressed (MDA231-PRRX1), and performed comparative
microarray analyses (GEO: GSE138078). SNAIL1 was down-
regulated after PRRX1 overexpression, reinforcing the idea of a
mutual negative regulation. Interestingly, we found many miR-
NAs that were upregulated in MDA231-PRRX1 cells (Fig. 3a and
Supplementary Data 1). As miRNA are potent regulators of gene
expression13, we hypothesized that Prrx1 may repress Snail1 via
recruiting miRNAs. We selected for further analyses miR-424 and
miR-503 that are members of miR-15 family (hereafter referred as
Mir-15-P1d and Mir-15-P2d, as recently suggested31; Supple-
mentary Table 2) because they were predicted to target Snail1, are
conserved in different vertebrates, have a relatively well known
promoter, and most importantly because their studied functions
as regulators of stemness, invasion, migration and cell prolifera-
tion32–34, are compatible with those described for PRRX18. We
validated the microarray data by qPCR analyses (Fig. 3b).
To test whether these miRNAs could be directly induced by
PRRX1, we examined the expression of their precursor miRNAs
(Pre-miRNAs) upon transient overexpression of mouse Prrx1 in
MDA231 cells. To do so, we generated an inducible lentiviral
system (Tet-ON) including P2A peptide and overexpressed both
Prrx1 and nuclear yellow fluorescent protein (nYFP)-P2A-Prrx1
(MDA231 conditional Prrx1; MDA231cP) upon doxycycline
(dox) treatment. Forty-eight hour after dox induction, YFP-
positive cells were FACS sorted and subjected to qPCR, showing
that, as expected, Prrx1 was overexpressed and also that Pre-
miRNAs were significantly upregulated (Fig. 3c and Supplemen-
tary Fig. 3a), suggesting that they may be direct Prrx1 targets.
As miRNA molecules of the same family share the seed
sequence (nucleotides 2–7) and they can potentially target the
same mRNAs, we examined whether the expression of other miR-
15 family (miR-15f) members (Supplementary Fig. 3b) also
correlated with that of PRRX1. Thus, we performed transient KD
of PRRX1 in BT549 cells with a specific short-hairpin RNA8
(shRNA) vector containing nYFP. We then FACS-sorted positive
cells, and checked pre-miRNAs expression for an early transcrip-
tional response. We observed that PRRX1 transcript was
significantly reduced, and also that all the members of the miR-
15f were significantly downregulated upon PRRX1 KD (Fig. 3d).
We also confirmed that this was the case in HEK293 cells
(Supplementary Fig. 3c).
To assess whether PRRX1 directly binds the miR-15f
promoters, we performed ChIP assays in BT459 on the human
Mir-15-P1/2d promoter. We found enrichment for PRRX1
binding in at least one putative BS, indicating that PRRX1 can
directly bind to the Mir-15-P1/2d promoter (Fig. 3e). Also,
PRRX1 overexpression increased the activity of the Mir-15-P1/2d
promoter, and the deletion of PRRX1 potential BS prevented this
activation (Fig. 3f). On the other hand, KD of PRRX1 in BT549
cells showed a reduction in promoter activity, confirming that
PRRX1 enhances Mir-15-P1/2d transcription (Supplementary
Fig. 3d). We also performed ChIP and Luciferase assays in
mouse NIH-3T3 cells and confirmed that this direct binding and
activation of the Mir-15-P1/2d promoter is conserved between
human and mouse (Supplementary Fig. 3e, f). Furthermore, ChIP
assays for Prrx1 in the promoter regions of other members of the
miR-15f in human and mouse, show that Prrx1 can directly bind
and likely activate other members of the family (Supplementary
Fig. 3g–i). Altogether, these experiments indicate that PRRX1 is
able to directly bind to the promoter, and activate the
transcription of miR-15f members.
To elucidate in vivo the relationship between Prrx1 and miR-
15f members we studied the expression of the miRNAs by ISH
using specific DIG-labeled LNA (locked nucleic acid) probes to
detect their mature versions in mouse embryos. At E8.5,
expression can be detected in similar territories to those of Prrx1,
e.g., MNC cells (Fig. 3g), suggesting that Prrx1 induces the
expression of these miRNAs in those territories. Altogether these
results indicate that miR-15f members are directly induced by
Prrx1 in vitro and in vivo.
Prrx1 indirectly attenuates Snail1 expression through miR-15.
We validated our microarray data (Fig. 3a) by qPCR, and con-
firmed that in MDA231-PRRX1cells, SNAIL1 is significantly
downregulated (Supplementary Fig. 4a). To assess whether this
was an early response, we examined SNAIL1 expression in the
inducible Prrx1 system. We analyzed MDA231-cPrrx1 cells after
48hs of dox induction and found that SNAIL1 was down-
regulated, confirming the microarray data also in a short-term
experiment (Fig. 4a).
The observed downregulation of SNAIL1 after constitutive and
short-term induction of PRRX1 expression together with the fact
that Prrx1 directly induces the transcription of miR-15f members
that were predicted to target Snail1 (Supplementary Fig. 4b),
suggested that Prrx1 could be attenuating Snail1 expression
through the activation of miR-15f members. Importantly, the
miRNA responsive element (MRE) in Snail1 3′ untranslated
region (UTR) is conserved in all vertebrates (Supplementary
Fig. 4c), and the in silico prediction for binding of human, mouse,
chicken, and zebrafish miR-15f members to the corresponding
Snail1 3′ UTRs suggest a strong hybridization not only in the seed
region but also in the 3′ end of the miRNAs (Supplementary
Fig. 4b, d–f). Thus, we examined whether Snail1 could be directly
targeted by miR-15f. We first overexpressed Mir-15-P1/2d in
MDA231, and found a significant downregulation of SNAIL1. As
a control, we overexpressed a seed-mutated version of the
miRNAs (Mir-15-P1/2d-mut), unable to bind to SNAIL1 3′ UTR
(Fig. 4b). Conversely, we used specific miRNA inhibitors/LNAs to
KD Mir-15-P1/2d in BT549, which express high levels of PRRX1
and miR-15, and that resulted in upregulation of SNAIL1
(Fig. 4c). To confirm that this downregulation was through
direct binding of the miRNAs to the 3’UTR, we performed
Luciferase assays and observed that overexpression of Mir-15-P1/
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2d repressed human SNAIL1 3′ UTR activity. This repression was
abolished when we used either the seed-mutant miRNAs or a
MRE-mutated version of the SNAIL1 3′ UTR (Fig. 4d). Moreover,
we checked other miR-15f members and found thatMir-15-P1/2b
behaves similarly (Supplementary Fig. 4g). This regulation is
conserved in mouse, chicken and zebrafish, as overexpression of
miR-15f members can repress Snail1 3′ UTR from those species
(Supplementary Fig. 4h–j), indicating that Snail1mRNA is a bona
fide target of miR-15f in vertebrates.
To test whether this regulation operates in vivo, we knocked-
down miR-15f in zebrafish embryos by injecting a sponge RNA35
containing partially complementary sequences to all miR-15f
members (Supplementary Fig. 4k). Zebrafish embryos were
injected at 1–2 cell stage and then collected at 20-somite stage.
qPCR from pools of embryos confirmed that snail1a/b transcripts
were more abundant in those injected with sponge (Fig. 4e). ISH
analysis showed that in one third (30/96) of the injected embryos,



























































































































































































































































































PRRX1 protein enrichment on
human Mir-15-P1/2d promoter
Fig. 3 Prrx1 directly induces the expression of miR-15 family. a Heatmap showing Robust Multi-array Average (RMA) normalized probe intensity values of
PRRX1, SNAIL1, and selected miRNAs in MDA231 cells, with three control samples (MDA_C1 to C3) and three samples in which PRRX1 was overexpressed
(MDA_P1 to P3). The intensities mapped as color scale show normalized fold change with respect to the average (n= 3). b Validation by Taq-Man qPCR of
Mir-15-P1d and Mir-15-P2d upregulation after PRRX1 stable overexpression in MDA231 cells lines, using specific probes to detect the mature miRNAs (n=
4). c Mir-15-P1d_pre and Mir-15-P2d_pre upregulation upon conditional (Dox-mediated) Prrx1 overexpression in MDA231 cells (n= 6). d qPCR assay
showing downregulation of PRRX1 and premiRNAs transcription upon transient knockdown (KD) of PRRX1 in BT549 cells. PRRX1 shRNA plus YFP
transfected cells were sorted after 4 days (n= 4). e PRRX1 directly binds to the humanMir-15-P1/2d promoter as shown by ChIP assay in BT549 cells using
a PRRX1 specific antibody. Cyan diamonds in the schematic map represent distances between PRRX1 potential BSs and the promoter potential motifs,
TAATKDS, on Mir-15-P1/2d promoter. (BS1: −293, BS2: −949, BS3: −1451 and NC: +1893). Ex1–3 represent exons of the host long noncoding RNA
MIR503HG. Arrows represent primer sets used for ChIP detection. (n= 3 except for BS2–3 for which n= 4). f Activation of human Mir-15-P1/2d promoter
by PRRX1 overexpression shown by dual luciferase assay in HEK293 cells. This activation is abolished upon deletion of the PRRX1 binding sites inMir-15-P1/
2d promoter (del1/2+ PRRX1) (n= 4 except for deletions for which n= 4). g Transverse sections of the cranial region of E8.5 embryos showing the
expression of Prrx1, Mir-15-P1d, Mir-15-P2d, Mir-15-P1b, and Mir-15-P2a/b in similar regions (arrowheads). Scale bar: 100 μm. Dox doxycycline, sh short
hairpin RNA (shRNA), BS binding site, del deletion. Bars represent mean plus SEM, indicated (n) represent number of independent experiments as
biological replicates and asterisks indicate significant p value in t test for (b–e) and one-way ANOVA with Bonferroni’s multiple comparison test for (f).
(*p < 0.05, **p < 0.01 and ***p < 0.001). Source data are provided as a Source Data file
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Fig. 4 Prrx1 attenuates Snail1 expression through the activation of miR-15 family members. a qPCR assay showing the downregulation of SNAIL1 upon
conditional overexpression of Prrx1 in MDA231, induced by doxycycline after 48 h (n= 7). b qPCR assay showing downregulation of SNAIL1 upon transient
overexpression ofMir-15-P1/2d in MDA231 cells, using seed mutated miRNAs as control (Mir-15-P1/2d-mut) (n= 6). c qPCR assay showing upregulation of
SNAIL1 upon transient KD of in Mir-15-P1/2d in BT549 cells using miRNA LNA inhibitors (n= 5). d Repression of human SNAIL1 3′ UTR after Mir-15-P1/2d
overexpression, using seed mutated miRNAs (Mir-15-P1/2d-mut) or MRE mutant SNAIL1 3-UTR (MRE-mut) as control (n= 5). e qPCR analysis shows
upregulation of snail1a/b expression in the sponge-injected (miR-15 family knocked-down) zebrafish embryos compared to controls (n= 6). f 20-somite
control or miR-15 family sponge-injected zebrafish embryos showing combined snail1a/b expression by in situ hybridization. Transverse sections taken at
the levels indicated by the dashed lines. Scale bar: 250 μm. g Fluorescent miRNA in situ hybridization to detect mature miRNAs in transverse sections of
20-somite zebrafish embryo, showing the expression of Dre-miR-15-P1/2a/b in neural crest derived cell populations. Scale bar: 250 μm. h Western blot for
Snail1 and β-actin from E11.5 control and Prrx1mutant embryos, including quantification of intensity of Snail1 signal (n= 5 WT, 4 KO). i Snail1 IF in the nasal
pit regions of E11.5 WT and mutant embryos. Scale bar: 250 μm for NP sections and 100 μm for insets (boxes 1 and 2). MRE miRNA responsive element,
LNA locked nucleic acid, WT wild type, Mut mutant, NT neural tube, NP nasal pit. Quantifications are performed for one section of WT or mutant embryos,
and the increase and expansion is observed in n= 2/2 mutant embryos compared to n= 3/3 different E11.5 WT. Bars represent mean plus SEM, indicated
(n) represent number of independent experiments as biological replicates and asterisks indicate significant p value in t test for a, c, e, h and one-way
ANOVA with Bonferroni’s multiple comparison test for (b), (d) (*p < 0.05, **p < 0.01 and ***p < 0.001). Source data are provided as a Source Data file
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confirmed the drastic increase in snail1 expression in the
territories of endogenous miR-15 expression (Fig. 4f, g). Some
embryos showed ectopic snail1 positive cells that migrated
beyond their normal position (Supplementary Fig. 4l, asterisk),
as may be expected for a Snail gain of function. These findings are
compatible with miR-15f attenuating snail1 expression in
zebrafish, confirming the results previously observed in cultured
cells and living embryos.
To assess whether the loss of Prrx1 protein also affects Snail1
levels in the mouse, we performed western blot analysis in Prrx1
mutant embryos (bearing a LacZ knock-in in the Prrx1 locus
(Prrx1tm1Jfm)36) (Supplementary Fig. 5a), and found a significant
increase of Snail1 protein levels compared with WT embryos
(Fig. 4h and Supplementary Fig. 9). Snail1 IF in cryo-sections
from E11.5 embryos (Fig. 4i and Supplementary Fig. 5b, d)
showed an increased expression and expansion of Snail1
territories in the head of mutant embryos, compatible with a
mutual Prrx1/Snail1 repression (Supplementary Fig. 5b–e and
Fig. 4i). Altogether, these findings are compatible with our
in vitro analyses and indicate that Prrx1 indirectly attenuates the
expression of Snail1 through the induction of miR-15f, a
mechanism that is conserved in vertebrates.
SNAIL1 and PRRX1-miR-15 correlation with patients’ prognosis.
As shown previously in breast and in lung squamous cell carci-
noma patients, high expression of SNAIL1 in tumors correlate
with poor prognosis8,11, while high PRRX1 correlates with good
prognosis8. We confirmed this notion analyzing breast cancer
patients’ overall survival (OS) from a different dataset37 contain-
ing different clinical conditions and subtypes, including tumoral
grade, ER/PR/HER2, lymph-node status, etc. (Total) (Fig. 5a).
These correlations are even stronger when we analyze patients
with lymph-node positive status (Fig. 5b). We also found that in
terms of patients’ OS the expression of miR-15f members have
similar profile to that of PRRX1, i.e., high expression of miR-15f
members correlate with better OS in total and lymph-node posi-
tive patients’ groups (Fig. 5a, b).
Breast cancer is highly heterogeneous, including several
different subtypes. Among all subtypes, triple-negative breast
cancer (TNBC) is classified as basal-like38 and has been associated
with EMT features and mesenchymal phenotype, also manifesting
worst prognosis and lowest response to therapy39,40. Therefore,
we examined the expression of SNAIL1/PRRX1 and miR-15f
members in patients with basal/TNBC subtype. Similar to the
results obtained with total patients, high expression of SNAIL1
significantly correlated with poor OS, while PRRX1 high
expression was concomitant with more favorable OS (Supple-
mentary Fig. 6). Also, three members of the miR-15f, out of the
four that were shown in total patients’ group, followed PRRX1
expression trend (Supplementary Fig. 6). Altogether, these results
indicate that similar to PRRX1, when miR-15 are expressed at
high levels in cancer patients, they are associated with better
prognosis, even in patients who have the cancer spread to their
lymph nodes and also in basal/TNBC subtype which comprises
the most unfavorable disease.
Snail1 and Prrx1 are sequentially expressed during EMT.
Snail1 seems to be the first EMT-TF to be expressed in regions of
the embryo that will undergo an EMT process, including the
primitive streak and the neural crest41. Snail genes (Snail1 in the
mouse and Snail2 in the chick) are expressed in the PNC before
delamination from the neural tube and continue to be expressed
in early migratory cells but their expression decays along the
migratory routes41,42. In contrast, Prrx1 is expressed in migratory
crest subpopulations (MNC; ref. 8 and this work). The expression
of these two EMT-TFs follows a temporal order in the migration
of the neural crest, and thus, likely reflects a hierarchy of acti-
vation during the EMT process that drives neural crest delami-
nation and migration. To test this idea, and taking into account
that both Snail and Prrx are activated by the TGF-β superfamily
members bone morphogenetic proteins (BMPs) during embryo-
nic development8,12, we first treated developing zebrafish
embryos from 4-somite stage with BMP and examined the levels
of snail1, prrx1 and miR-15f members by qPCR. snail1b was
quickly upregulated, while prrx1a/b and miRNAs were induced
later, concomitant with downregulation of snail genes (Fig. 6a).
To test this hypothesis in other species, we implanted BMP-
coated beads close to somites in developing chicken embryos, and
monitored the expression of these two EMT-TFs at different time
points. SNAIL1 was quickly upregulated 1 h after bead implanta-
tion, whereas PRRX1 upregulation was observed after 5 h (Fig. 6b),
supporting the notion of sequential activation of these EMT-TFs.
In line with our findings in zebrafish, SNAIL1 transcripts were
reduced in the somites close to the bead after longer BMP
treatment, while PRRX1 was still upregulated in similar somite
regions (Fig. 6b). We also found that the peak of SNAIL1 protein
expression occurred after 5 h, and that of PRRX1 protein after 10
h (Supplementary Fig. 7a, b). This suggests that although SNAIL1
transcription is quickly upregulated, the increase in protein level
takes longer, allowing a slower PRRX1 activation by BMP, that
will gradually outcompete SNAIL1 expression.
To examine whether this sequential activation was also
conserved in the mouse, we used a transgenic model containing
a downstream enhancer of Snail1 (DES) that drives the expression
of enhanced green fluorescent protein (EGFP) to its endogenous
territories, recapitulating the vast majority of Snail1 expression in
the developing embryo (Snail1 (DES)-EGFP reporter mouse;
Supplementary Fig. 8). The half-life of the GFP protein is very
long43 whereas Snail1 protein is very unstable44, thus, this model
can provide a short-time lineage tracing system. In transverse
sections of E8.5 embryos, we observed that PNC and early MNC
cells expressed Snail1 and GFP, while late MNC cells are negative
for Snail1 protein but positive for both GFP and Prrx1 (Fig. 6c).
This observation is compatible with the idea that Snail1 and Prrx1
are expressed in a sequential manner, as Prrx1 positive cells seem
to be descendants of Snail positive cells (double-labeled cells in
Figs. 6c box4). Altogether, these results suggest that during
embryonic development, cells undergo EMT by activating Snail1
first, and then attenuation of Snail1 is indirectly mediated by
Prrx1 though the activation of the miR-15f, all being part of a
GRN in which miR-15f may coordinate the transition from
Snail1- to Prrx1-mediated EMT programs (Fig. 6d).
Discussion
Epithelial cells transition to a variety of mesenchymal states to
fulfill different roles in different contexts. The existence of diverse
mesenchymal cells allows for a high degree of cell heterogeneity
in terms of potential fates and therefore, functions. They are all
called mesenchymal based on morphology, the expression of
particular markers (although there is no universal marker to
define them), and very often, their ability to migrate. Differences
arise from the tissue of origin as these phenotypic transitions are
governed by extracellular signals that activate a plethora of EMT-
TFs.
Here, we show that Snail1 and Prrx1 are expressed in a com-
plementary manner during vertebrate development and in cancer
patients. Considering that all EMT-TFs are activated by the same
extracellular signals, this strongly suggests that Snail1 and Prrx1
may be part of a mutual regulatory network. In this work, we
describe such a mechanism. We find that Snail1 and Prrx1 behave
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as mutual repressors, albeit they use different mechanisms.
Although in some contexts Snail1 can function as an activator45,
it is mostly a strong transcriptional repressor26,46, and this is the
mechanism that it uses to repress Prrx1 expression. Prrx1, in turn,
is a transcriptional activator30 and accordingly, here we show that
it represses Snail1 indirectly through the activation of a repressor,
miR-15f. As miR-15f is composed of eight members in four dif-
ferent clusters, this provides a certain degree of variability in the
repression, e.g., one or several family members can be used in
specific cell contexts to exert a particular level of repression.
Following the developmental time in a particular tissue, it is
possible to infer potential regulatory scenarios in which the
mutual repression of these TFs could be integrated. For instance,
in the mouse, Snail1 is expressed in the PNC and Prrx1 is
expressed in subpopulations of MNC. During somite formation,
Snail1 is expressed in the precursors of the whole somite and,
later on in the mature somites, it is expressed in the SC and Prrx1
in the DM, also showing complementary expression. This implies
that Prrx1 is activated in some descendants of Snail1 expressing
cells. Altogether, this points to the successive upregulation of
EMT-TFs during the development of the neural crest and the
somites, providing a hierarchical temporal order in the activation
of these two TFs. As such, we provide evidence of this temporal
hierarchy both in vitro and in vivo, with Snail1 being activated at
earlier time points in response to an EMT-inducing signal.
Interestingly, the inducing signal is the same for Snail1 and
Prrx1 (the TGF-β superfamily8,12 and this work), and thus, the
question is why they are not simultaneously activated when the
signal is available in the embryo or in cancer cells. One expla-
nation is that Snail1 bears a poised promoter47, explaining why it
usually is an early response gene activated shortly after TGF-β
administration48. Snail1 fast activation may set an inhibitory
scenario for Prrx1 upregulation, which may change when the
duration of the TGF-β signal accumulates sufficient stimulus to
induce Prrx1. This establishes a temporal order of predominant
EMT programs, firstly mediated by Snail1, a strong epithelial
repressor needed for cells to detach from their neighbors. Sub-
sequently, Prrx1, a strong mesenchymal inducer, is activated and
in turn, it will promote the acquisition and maintenance of robust
mesenchymal features for cells to migrate to their destination.
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Fig. 5 Relationship between the expression of SNAIL1, PRRX1, and miR-15 family members and overall survival in breast cancer patients. Kaplan–Meier
overall survival (OS) plots from breast cancer patients with lymph-node positive status, showing that high expression of SNAIL1 correlates with low
survival, while PRRX1 high expression correlates with a better survival. The expression of miR-15 family members follow a similar trend as that of PRRX1.
Hazard ratio (HR) and logarithmic ranked p Value (longrank P) were analyzed to infer the significance of the differences. Numbers below each graph
represent number of patients at risk in any given time (months), black for low expression and red for high expression of each gene/miRNA. The cut-off is
automatically calculated based on the best performing threshold
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Fig. 6 Snail1 and Prrx1 are sequentially expressed during EMT. a qPCR assay showing the expression of prrx1a/b and snail1a/b (left) and premiRNAs (right)
in zebrafish embryos after different treatments with BMP (n= 8). Asterisks indicate significant p value in one-way ANOVA with Bonferroni’s multiple
comparison test compared to the control. (*p < 0.05, **p < 0.01 and ***p < 0.001). Source data are provided as a Source Data file. b Dorsal view of HH9
chicken embryos showing SNAIL1 and PRRX1 expression in control embryos and at different times after BMP-soaked bead implantation. c Transverse
sections of E8.5 DES-EGFP reporter mouse embryos showing IFs for GFP and Snail1 (upper panel) or Prrx1 (lower panel). Insets show higher magnification
pictures for GFP and Snail1 (1 and 2), or for GFP and Prrx1 (3 and 4). d Schematic model of the gene regulatory network. DES downstream enhancer of
Snail1, PNC premigratory neural crest shown by arrows, MNC migratory neural crest. Scale bars: 100 μm. Scale bars: 100 μm for sections and 10 μm for
insets (boxes 3–4)
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Cells do not only express these two TFs but also members of the
other EMT-TF families in a context-dependent combination that
will determine their final phenotype. Nonetheless, Snail1 and
Prrx1, as shown here, are mutually exclusive, thereby promoting
their own mode of EMT. We also describe in this work that Prrx1
further reinforces its own program by activating its own pro-
moter. Interestingly, Snail1 represses its promoter, thereby
modulating its own expression49. This can also contribute to the
establishment of the temporal hierarchy of EMT-TF activation,
promoting Prrx1 upregulation, as we observe during embryonic
development. Altogether, these mutual regulations and the
response to the inducing signal establish a GRN that controls the
EMT programs.
Snail1 and Prrx1 EMT programs differ in some important
aspects. As such, EMT has been associated with the acquisition of
stem cell properties6 but Prrx1 represses stemness8,9. This
impinges into the plasticity required in both embryonic and
cancer cells to revert to a more epithelial phenotype at the site of
their final destination either to differentiate into different organs
during development or to form macrometastases during cancer
progression (see refs. 8 and 50–52). Prrx1 needs to be down-
regulated in cancer cells to promote the reversion, and its
downregulation implies an increase in stem cell properties that
are also essential for metastatic growth. This explains why there is
a positive correlation between high levels of Prrx1 and better
prognosis in cancer patients8. Those cells may be stuck at a very
mesenchymal state, lacking the plasticity required to colonize and
restart proliferation in distant organs. In addition, as we have
found that miR-15f members are direct targets of Prrx1, Prrx1
high levels will lead to miR-15 activation, resulting in Snail1
attenuation, promoting a decrease in stem cell properties and
therefore in metastatic abilities. In agreement with that, we find
that miR-15 expression also correlates with better survival rate in
patients. However, we cannot exclude that other regulatory cir-
cuits impinging on Snail1 expression also play a role, including
the well described Snail1/miR-34 and miR-200 reciprocal feed-
back loops14.
Importantly, the relationship between EMT and stemness has
been mainly studied in adult mammary gland and in cancer
cells6, but these differences in conferring stem-like cell properties
may also have a role during embryonic development. Snail1
expressing cells might be in more stem state, as they can give rise
to cells with a variety of fates. For instance, Snail1 is expressed
early in primitive streak and the premigratory neural crest, both
of which later give rise to a large variety of cell types53. As such, it
has been proposed that the premigratory neural crest may still
retain characteristics of the pluripotent blastula stage54. These
multipotent territories do not express Prrx1, which is rather
expressed in cells that have been already committed to particular
lineages such as specific mesodermal or crest subpopulations.
This is also compatible with the already discussed temporal
hierarchy in the activation of these two EMT-TFs that occurs in
parallel with commitment to different fates.
As much as Snail1 and Prrx1 trigger different EMT programs8,
they have important common functional roles inducing the
transition towards a mesenchymal state, activating invasion and
migration and attenuating proliferation. Snail1 induces migration
and invasion in many different contexts through activation of a
variety of factors including matrix metalloproteinases that enable
cells to break the basal lamina and delaminate55,56, and attenuates
proliferation by repressing the cyclin D transcription57. Prrx1 also
decreases cell proliferation and induces invasiveness8,58. Here, we
show that some roles of Prrx1 are mediated by miR-15, such as
promoting its own EMT mode by attenuating Snail1 expression.
Interestingly, some miR-15f members have previously been
associated with regulating cell proliferation, migration and
invasion32–34, suggesting that in addition to Snail1, they have
other targets that impinge into particular characteristics of the
EMT process.
Overall, in this work, we describe a GRN that operates in
development and in disease to regulate the activation of different
EMT programs, providing a superimposed degree of controlled
heterogeneity required for the EMT, a crucial and complex pro-
cess, fundamental for organ formation and cancer progression.
Methods
Cell culture. MDA-MB-231 (MDA231), MDA436, BT549, and SUM149PT human
breast tumor cell lines, HEK293 human embryonic kidney and NIH3T3 mouse
fibroblast cells were purchased from the ATCC (Virginia, USA) and ASTERAND
BIOSCIENCE. MDA231, MDA436, and BT549 human tumor cell lines were cul-
tured in DMEM:F12 HAM media (1:1), and SUM149PT cells in F12 HAM media,
supplemented with 10% heat inactivated fetal bovine serum (FBS) (Sigma),
10 μg/ml insulin (Roche), 1% Gentamicin (Sigma), and 1% amphotericin (Sigma).
HEK293 cells were cultured in DMEM supplemented with 10% heat inactivated
FBS (Sigma) and 1% Gentamicin (Sigma) 1% amphotericin (Sigma). NIH3T3 cells
were cultured in DMEM supplemented with 10% heat inactivated calf new-born
serum (Sigma), 1% amphotericin (Sigma) and 1% Gentamicin (Sigma). Cells were
kept at 37 °C and 5% CO2, and the media was replaced every 2/3 days. HEK293
cells were passaged when they reached 80% confluency 1:10 every 48 h, while
BT549 and MDA231, MDA436, and SUM149PT cells were passaged when reached
80% confluency 1:5 every 72 h. Cells were discarded after up to five consecutive
passages and replaced by freshly thawed stocks. All cell lines were tested and
confirmed negative for mycoplasma on a monthly bases at the host institution. All
the cell lines were authenticated using STR profile by the Genetic Analysis Service
at Miguel Hernandez University, Spain.
Microarray analyses. MDA231 human breast cancer cell line was transduced
using a lentiviral system to stably express control GFP (MDA231-Control,
MDA231-C) and PRRX1 (MDA231-PRRX1, MDA231-P)8. Three independent
samples per condition from MDA231-C and MDA231-P cells, were hybridized to
Human Gene 2.0 ST expression arrays (Affymetrix). Microarray data were ana-
lyzed using R and Bioconductor59. Expression data was preprocessed and nor-
malized using the RMA algorithm60, and differential expression analysis was
performed using limma61 t test to extract statistically significant changes between
PRRX1 and control samples. Accordingly, the genes that have a log2 fold change >
1.5 and corrected p value < 0.05 (Benjamini–Hochberg FDR) were considered as
being differentially expressed.
Plasmid constructs and interfering RNAs. For overexpression studies, human
PRRX1 ORF (ENSG00000116132) was cloned in the pBABE expression vector, and
mouse Prrx1 ORF (ENSMUSG00000026586) was cloned in the pCDNA3.1
expression vector. Lentiviral vectors were generated via subcloning nuclear yellow
fluorescent protein (nYFP) followed by P2A and mouse Prrx1-L open reading
frame into pTRIPZ construct. P2A is a short peptide derived from porcine
teschovirus-1 which mediates production of equimolar levels of Prrx1 protein
sequence plus the nYFP reporter62. For RNA interference in BT549 cells, nYFP
under hPGK promoter was subcloned into pLKO.1 construct containing
PRRX1 specific shRNA (Dharmacon, RHS3979–201751764, Mature antisense:
TTATTGGCTAGCATGGCTCTC)8. For RNA interference in MDA436 cells,
specific siRNAs were used for SNAIL1 and PRRX1 (SNAIL1 siRNA (antisense):
UGGCACUGGUACUUCUUGACAUCUGtt and PRRX1 siRNA (antisense):
GAUGACUAAAUGGUAUUCCtt). PRRX1 siRNA was obtained from Silencer®
predesigned (Ambion). For miRNA overexpression studies, approximately 150
base pairs up- and downstream of the stem–loop sequences of each miRNA pair
(obtained from www.mirbase.org) were cloned into the pcDNA3.1 vector. 3’ UTRs
of mouse, human, chicken and zebrafish Snail1 were cloned downstream of Firefly
luciferase ORF in pGL3 basic vector. Promoters of human and mouse Mir-15-P1/
2d as well as human and mouse Prrx1 plus human PRRX1 upstream (enhancer-
like; containing BS7) region (−7046 to −6439) were cloned upstream of the Firefly
luciferase ORF in pGL3 basic vector, which contains a minimal promoter, con-
sidering cases to analyze DNA segments lacking promoter activity. For Snail1
reporter assay, mouse Snail1 promoter cloned in pXP1 luciferase construct63 was
used. For mutagenesis, primers were designed using the online tool https://www.
agilent.com/store/primerDesignProgram.jsp. PCR was performed using Pwo
polymerase following manufacturer’s instructions, and PCR products were treated
with DpnI restriction enzyme, then transformed in bacteria to be amplified,
extracted using Mini-prep and then sequenced to confirm the mutation/deletions.
All constructs were generated using the primers described in Supplementary
Table 3.
Transfection of plasmids and interfering RNAs. BT549 cells were transfected
with either control pLKO.1 vector or PRRX1 specific shRNA8 using Lipofectamin
3000 (Invitrogen) following the manufacturer’s instructions. 500,000 cells were
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seeded in 10 cm plates 24 h prior transfection. Five days post transfection YFP-
positive cells were fluorescence-activated cell sorting (FACS) (BD FACSARIA III,
USA) sorted directly collected into lysis solution from mirVanaTM miRNA Isola-
tion Kit and subjected to RNA extraction. For LNA transfection, 250,000 BT549
cells were seeded in 6-well plates 24 h prior transfection, and 48 h after transfection
cells were lysed for RNA extraction. HEK293 cells were transfected using the same
procedure. MDA231 cells were transfected with pCDNA3.1 vectors for miRNA
overexpression using Lipofectamin 3000 (Invitrogen) following the manufacturer’s
instructions. 200,000 cells were seeded in 6-well plates 24 h prior transfection, and
48 h after transfection cells were lysed for RNA extraction.
Dual luciferase reporter assay. HEK‐293 and BT549 cells were cultured in 24-
well plate 10 h before transfection. Cells were seeded in triplicate and transfected
with 100 ng of the constructs containing sequences for promoters or 3’UTRs
cloned in pGL3P vector, 50 ng of the pRL control vector (Renilla luciferase) and
200 ng of the pcDNA3.1 plasmid subcloned with different transgenes for pre-
miRNA or Prrx1/Snail1 overexpression, using the Lipofectamin 2000 (Invitrogen).
The media were refreshed 12 h after transfection. After 48 h, the cells were lysed
using 5× lysis buffer (Promega), and the enzymatic activity was analyzed after
adding Luciferase Assay and Stop&Glo reagents (Promega), to measure Firefly and
Renilla successively, using Sirius Luminometer (Berthold, Germany).
Lentiviral infection. MDA231 cells were infected by pTRIPZ inducible lentiviral
system containing nuclear nYFP-P2A-Prrx1 or control vectors with turbo RFP.
The pool of infected cells was selected by treatment with puromycine for 48 h.
Infected cells were seeded in 10 cm dishes, subjected to 2μg/ml doxycycline to
induce the Tet-ON promoter (tetracycline-controlled transcriptional activation
that is induced upon presence of antibiotic tetracycline or one of its derivatives,
doxycycline) and FACS-sorted after 48 h for either YFP or RFP positive signals for
Prrx1 overexpressing or control cells, respectively. Cells were collected immediately
after sorting in lysis solution from mirVanaTM miRNA Isolation Kit (Invitrogen).
Total RNA extraction cDNA synthesis and qPCR analysis. For gene expression
assays, total RNA was extracted using the illustra RNAspin Mini isolation kit (GE
Healthcare), following the manufacturers’ instructions. For Reverse transcription
cDNA synthesis, oligo (dT)18 and random hexamer primers with the Maxima First
Strand cDNA Synthesis kit (Thermo Scientific) were used, following the manu-
facturers’ instructions. Primers used are listed in Supplementary Table 3. Quan-
titative RT-PCR was performed using Fast SYBR Green Mastermix (Applied
Biosystems), in a Step One Plus machine (Applied Biosystems) according to the
manufacturers’ instructions. Relative levels of expression were calculated using the
comparative Ct method normalized to the internal control TBP housekeeping gene.
For mature miRNA expression assays, total RNA enriched for small RNAs was
extracted using mirVanaTM miRNA Isolation Kit (Invitrogen), following the
manufacturers’ instructions. Reverse transcription reactions were performed using
TaqMan® MicroRNA Assay (Applied Biosystem) according to the manufacturers’
instructions. For quantitative real-time retro-transcriptase PCR (qPCR), specific
probes from TaqMan®MicroRNA Assay (Applied Biosystem) were used (Catalog #
4427975, hsa-miR-424-5p Assay ID: 000604 and hsa-miR-503–5p Assay ID:
001048). TaqMan® Universal Master Mix II, no UNG (Applied Biosystems) was
used, in a Step One Plus machine (Applied Biosystems) according to the
manufacturers’ instructions. Relative levels of expression were calculated using the
comparative Ct method normalized to the internal control U6 snRNA.
ChIP assay. Parental BT549 cells, BT549 cells transfected with SNAIL1-MYC and
NIH-3T3 cells were used for ChIP assays for each indicated experiment. Cells were
collected when at 80% confluency from 10 cm culture dish after trypsinization, and
fixed in 1% PFA 15min, and subsequently quenched with 0.125 M glycine for 15
min. Next, cells were lysed in 300 μl of lysis buffer (1% sodium dodecyl sulfate
(SDS), 10 mM EDTA 50 mM Tris-HCl pH 8, protease inhibitor cocktail) on ice for
10 min. Lysates were sonicated four times for 15 min each in Bioruptor (H, 30” on/
30” off). Sonicated lysates were then diluted to 5 ml with dilution solution (0.01%
SDS, 1% Tx100, 2 mM EDTA, 20 mM Tris-HCl pH 8, 150 mM NaCl, protease
inhibitor cocktail). Aliquots were de-crosslinked and ran in agarose gel to check for
proper fragmentation. Samples were used for antibody incubation overnight at 4 °C
in a rotating rotor. IgG was used as control for normalization and Histone H3 was
used, at least in one of the replicates, to ensure efficient precipitation. Information
and dilution for antibodies are listed in Table 1. Protein A coupled magnetic beads
(Biorad) were blocked overnight with 0.05% bovine serum albumin (BSA), 2 μg/ml
of salmon sperm DNA in dilution solution. Antibody and control fractions were
then incubated with the magnetic beads for 4 h at 4 °C in a rotating rotor, and
subsequently washed with Wash buffers (WB) 1 (0.1% SDS, 1% Tx100, 2 mM Tris-
HCl pH 8, 150 mM NaCl), WB 2 (0.1% SDS, 1% Tx100, 2 mM Tris-HCl pH 8, 500
mM NaCl), WB 3 (1% NP40, 1% sodium deoxycholate, 10 mM Tris-HCl pH 8, 1
mM EDTA, 0.25 mM LiCl), and finally with WB4 (10 mM Tris-HCl pH8 and 1
mM EDTA). 10% CHELEX was added to the samples and then de-crosslinked at
95 °C for 10 min, Proteinase K treated (2 μg/ml) at 55 °C for 30 min and inactivated
at 95 °C for 10 min. Supernatant was used for direct qPCR reaction (2.5 μl).
RNA in situ hybridization. Whole-mount RNA ISH64 was carried out using
digoxigenin-labeled probes synthesized from mouse, chicken and zebrafish Snail1 and
Prrx112,41. Mouse, chicken and zebrafish embryos were fixed in 4% PFA-DEPC O/N.
Zebrafish embryos were then dechorionated in cold 4% PFA-DEPC. Embryos were
washed in PBS 0.1% Tween 20 (PBS-T). Next, embryos were dehydrated through a
series of increasing methanol concentrations in PBS-T (25, 50, 75, and 100%) and
kept O/N at −20 °C. Then, they were rehydrated through methanol:PBS-T in reverse
order and washed in PBS-T at the end. For fluorescent ISH, embryos were incubated
in 1% hydrogen peroxide (H2O2) for 10min, and then washed with PBS-T.
Depending on species and developmental stage, embryos were treated with 10 μg/ml
proteinase K in PBS-T between 3 and 6min at room temperature. Then they were
refixed with 4% PFA-DEPC, and washed. Embryos were then incubated with pre-
hybridization solution (50% formamide, 5× SSC, 2% Boehringer blocking powder,
0.1% Tween 20, 50 μg/ml heparin, 1mg/ml t-RNA, 1mM EDTA, 0.1% CHAPS) at 60
C̊, and then O/N upon refreshing prehybridization solution. Embryos were either
used the next day for ISH or stored at −20 C̊.
Prehybridized embryos were incubated with 1μg/ml of DIG or FLUO probes O/
N at 60 ̊C. The next day, embryos were washed several times first with 2X SSC,
0.1% CHAPS and then 0.2X SSC, 0.1% CHAPS, and then with KTBT washing
buffer (50 mM Tris-HCl pH7.5, 150 mM NaCl, 10 mM KCl, 0.1% Triton X-100 in
H2O). After the washes, embryos were incubated in blocking solution (15% sheep
serum, 0.7% Boehringer blocking solution, 0.1% Triton X-100 in KTBT) for 3 h at
4 °C. Then embryos were incubated with antibodies (1/1000 anti-DIG-AP, 1/500
anti-DIG-POD or anti-FLUO-POD, depending on the experiment) in blocking
solution O/N at 4 °C. The whole next day, embryos were washed many times in
KTBT buffer and kept O/N in KTBT at 4 °C.
For bright field ISH (chemical development of signal) embryos were washed in
NTMT (100 mM Tris-HCl pH9.5, 59 mM MgCl2, 100 mM NaCl, 0.1% Tween-20,
1 mM levamisole in H2O) buffer three times prior to developing the signal.
Embryos were then incubated with NTMT containing freshly added 3 μl NBT and
2.6 μl BCIP per 1 ml (developing solution), in the dark at RT until the color
reaction develops. After obtaining the desired signal level in positive tissues,
embryos were washed several times in KTBT and left O/N at 4 °C. After
hybridization embryos were fixed in 4% PFA, washed in PBS and imaged in a Leica
M125 dissecting scope with a Leica DFC 7000T digital camera (Leica, Wetzlar,
Germany). Some embryos were embedded in paraffin or gelatin, and sections were
obtained at 7 or 30 μm, respectively. Sections were photographed under a Leica
DMR microscope (Leica, Wetzlar, Germany).
For double-fluorescent ISH, DIG, and FLUO labeled probes were mixed and
added to the hybridization solution. After the washing steps with SSC buffer and
blocking, embryos were incubated with the first antibody (anti-DIG-POD or anti-
FLUO-POD). The next day, after two times washing with KTBT, embryos were
incubated with Amplification solution (TSA® fluorescein detection kit,
PerkinElmer) for 2 min to adjust the pH. Cy3 or FITC were added to the
Amplification solution for developing red or green colors, respectively. The
embryos were then incubated in the mix for 45 min in the dark at room
temperature. Next, the samples were washed 5 times in KTBT, and incubated in 2%
H2O2 for 2 h, then washed 5 times in KTBT. Embryos were then incubated in
blocking solution for 3 h at 4 °C, prior to adding the second antibody (anti-DIG-
POD or anti-FLUO-POD) in which they were incubated O/N at 4 °C. Information
and dilution for antibodies are listed in Table 1. The next day, fluorescent
developing procedures were repeated for the other color, plus stained with DAPI.
After washing in KTBT, embryos were imaged with Olympus FV1200 confocal
microscope and subjected to mosaic merge using Image J software, for pictures of
whole-mounted embryos. Some embryos were embedded in 4% low-melting
agarose and sectioned using a Leica VT1000S vibratome at 200 μm and subjected to
confocal microscope imaging.
miRNA in situ hybridization. For mature miRNA ISH the mouse miR-322 (Mir-
15-P1d), miR-503 (Mir-15-P2d), miR-15b (Mir-15-P1b), miR-16 (Mir-15-P2a/b)
and scramble LNA probes, which were 5′–3′ DIG labeled, were purchased from
Exiqon. ISH was performed on 10 μm frozen embryo sections, using the EDC
method65. Dried cryo-sections were treated with 20 mg/ml proteinase K (pH7.4) in
Tris-buffered saline (TBS) 1× (for 10× TBS, 69.6 g Tris, 87.6 g NaCl+ 800 ml
water, adjust pH to 7.6 and add water up to 1 L) for 20 min at RT, then washed 2
times in TBS and fixed in 4% PFA for 10 min at room temperature. Then, sections
were washed once with TBS 0.2% glycine for 5 min, and washed twice with TBS.
Samples were then incubated twice for 10 min in Imidazole 0.13M buffer (for
160 ml of buffer, 1.6 ml of 1-Methylimidazole was added to 130mlof water, pH was
adjusted to 8 with HCl, and then 16 ml of NaCl 3 M was added and then water to
final volume). Sections were fixed in 1-ethyl-3-(3-dimethylaminopropyl)
carbodiimide (EDC) solution (176 μl of EDC (Sigma) was added to 10 ml of
Imidazole buffer, then pH was readjusted to 8 by adding HCl) for 3 h at room
temperature. Samples were washed once with TBS 0.2% glycine, and twice with
TBS. Next, freshly prepared 0.1 M Triethanolamine (TEA), 05% acetic anhydride
was added for 30 min at room temperature. After washing twice with TBS, the
sections were prehybridized with hybrid-mix solution (50% formamide, 5× SSC, 5×
Denhardt’s solution (Applichem), 250 µg/ml yeast tRNA (Sigma), 500 µg/ml
salmon sperm DNA (Sigma), 2% (w/v) Blocking Reagent (Roche), 0.1% 3-
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[(3-Cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPs) (Sigma),
0.5% Tween) for 2 h at room temperature.
For hybridization, 4 pmol of DIG-labeled LNA probes were diluted in of
hybrid-mix solution for each slide, and covered with Parafilm M (Sigma). The
slides were kept in a sealed humidified chamber for at least 16 h at a temperature
20 °C below the melting temperature of the miRNA–LNA probes. Next day,
sections were washed twice for 30 min in washing solution (50% formamide, 1X
SSC, 0.1% Tween 20) at hybridization temperature, and then washed once with
0.2% SSC for 15 min at room temperature plus one wash with TBS 0.1% Tween 20.
Slides were then incubated with 3% hydrogen peroxide, 0.1% Tween 20 in TBS for
30 min, and then washed 3 timed in TBS 0.1% Tween 20 at room temperature.
Subsequently, sections were blocked by adding 0.5% Blocking Reagent (Roche),
10% sheep serum, 0.1% Tween 20 for 1 h at room temperature. Then, samples were
incubated with anti-DIG antibody in blocking solution O/N at 4 °C. Information
and dilution for antibodies are listed in Table 1. The next day, sections were washed
5 times with TBS 0.1% Tween 20, and incubated in NTMT buffer 3 times. Slides
were next immersed in chambers containing developing solution (details in RNA
ISH) at 37 °C until the color reaction developed. The sections were then washed
several times in TBS and fixed in PFA before being photographed under a Leica
DMR microscope (Leica, Wetzlar, Germany).
Generation of the Tg(hsp68-GFP-DES1)54An mouse transgenic line. The Tg
(hsp68-GFP-DES1)54An line was generated after pronuclear injection of the vector-
free reporter construct into FVB/NJ mouse blastocysts. The reporter construct
contains mouse hsp68 (HSPA1A) minimal promoter (−872 to +1) driving eGFP
followed by the SNAIL1 DES1 region (Downstream Enhancer SNAIL1). DES1
region contains the last 335 bp of SNAIL1 exon 3 and 1396 bp downstream of the
gene. This region was cloned by PCR with the following primers: mmDES1-F 5′
GGATCCGCAGGGTGGTTACTGGACAC 3′ and mmDES1-R 5′
TGTCGACTCCTCCTCCCTCTCTGGAAT 3′. Founders were screened for the
presence of GFP and they were mated to C57BL/6J mice to establish a line. Germ
line transmission was tested both by PCR and GFP expression in E9.5 embryos.
Two independent founders showed the same expression pattern and one of them
(line 54) was backcrossed to C57BL/6J mice and used for further analysis.
Mouse, chicken, and zebrafish embryo sections. C57BL/6J wild-type mice were
used. Embryos were staged as embryonic day (E) according to days post coitum.
Wild-type Zebrafish strain AB were maintained at 28 °C under standard condi-
tions, and the embryos were staged using zebrafish standard staging system66.
Fertilized hen eggs were incubated in an humidified incubator at 37 °C, and
embryos were staged based on Hamburger-Hamilton system67.
For ISH to detect mRNA (see protocol above), mouse and chicken embryos
were dehydrated through a series of increasing methanol:PBS-T series (25, 50, 75,
and 100%) and twice in butanol, then embedded in paraffin O/N. Sectioning was
performed in a Leica RM2245 microtome at 7 μm thickness.
For ISH to detect mature miRNA, mouse embryos were fixed in 4% PFA-DEPC
(Diethyl pyrocarbonate) O/N. The next day embryos were washed twice with PBS,
0.1% Tween 20 before being embedded in 15% sucrose. Upon sinking, embryos
were embedded in 30% sucrose, and after sinking they were kept in fresh 30%
sucrose O/N. Embryos were then kept in a 1:1 mix of 30% sucrose:OCT for 30 min
while rolling, before embedding in OCT. Embedded embryos were kept on dry ice
and transferred to −80 °C before sectioning. OCT-embedded embryos were
cryosectioned in a Slee MNT cryotome at 10 μm, dried for 2 h at room temperature
before either being directly used for ISH (see protocol below) or stored at −80 °C.
Zebrafish embryos that were subjected to double-fluorescent ISH (see protocol
below) were directly embedded in 4% low-melting agarose and sectioned using a
Leica VT1000S vibratome at 100 μm, mounted using Dako fluorescent mounting
medium and subjected to Confocal microscope imaging.
We affirm to have complied with all relevant ethical regulations for animal
testing and research. All animal procedures were conducted in compliance with the
European Community Council Directive (2010/63/EU) and Spanish legislation.
The protocols were approved by the CSIC Ethical Committee and the Animal
Welfare Committee at the Institute of Neurosciences, Alicante.
miR-15 family sponge generation and injection in zebrafish. We designed miR-
15 sponge as inhibitors that can quench all members of the family35, with the
following sequence, ATCGTCGTAGTCATACCAAAAGCAATTCC (Supplemen-
tary Fig. 4k), in three consecutive repeats and cloned in pCS2 construct. Com-
plementary sequences were chosen again conserved sequences among different
family members, and few spacer nucleotides in between serve make bulges that can
be recognized by the cell degradation machinery35. After linearization of the vector
to synthesize the sponge transcripts followed by SV40 poly A, RNA was synthe-
sized using the mMESSAGE mMACHINE SP6 Kit (Ambion) following manu-
facturer’s indications prior injection in zebrafish.
For zebrafish embryo injections we first titrated the non-toxic effective dose of
synthesized miR-15 family sponges to be injected safely. 100 ng of sponges were
injected in the yolk of 1–2 cell stage embryos and incubated at 25 °C. At 20-somite
stage, embryos were collected and fixed in 4% paraformaldehyde overnight at 4 °C
for ISH or collected and lysed immediately for RNA extraction.
Immunofluorescent (IF) staining. Whole-mount mouse and chicken embryos
were fixed in 4% PFA for 2 h at 4 °C. Then, embryos were dehydrated in a series of
PBS 1% Triton x100 (PBS-T):methanol proportions (25, 50, 75, and 100%), then
kept in 100% methanol O/N at −20 °C. Embryos where then rehydrated in the
reverse order of PBS-T:methanol proportions. Antigen retrieval was performed by
treating the mouse embryos with either 150 mM Tris-EDTA pH 9.0 (for Prrx1) or
10 mM Sodium Citrate pH 6.0 (for Snail1)-1% Triton x100 buffer at 70 °C for 20
min, following three washes with PBS-T. Embryos were blocked with 5% NGS 1%
BSA 1% Tx-100 for 5 h or O/N at 4 °C and then incubated with the primary
antibodies 48 h at 4 °C. After several washes for several hours in PBS-T, the
embryos were incubated with the secondary antibodies and DAPI O/N at 4 °C.
After washing the secondary antibody with PBS-T, embryos were subjected to
imaging. Pictures of whole-mount embryos were taken with an Olympus FV1200
confocal microscope with 10/20× objective and then subjected to mosaic merge
using Image J software. Information and dilution for antibodies are listed in
Table 1.
For cell lines IF, cells were cultured and treated on cover-slips in 6-well plates
and collected at corresponding time points, fixed with 4% PFA for 15 min at room
temperature, and washed three times with PBS. After washing fixed cells were
either directly subjected to IF or stored at 4 °C. Cells were blocked with 5% NGS 1%
BSA 0.2% Triton x-100 1 hour at room temperature and incubated with the
primary antibodies O/N at 4 °C. After washing three times with PBS, cells were
incubated with the secondary antibodies and DAPI 1 h at room temperature.
Information and dilution for antibodies are listed in Table 1. After washing the
secondary antibody with PBS, cells were photographed. Pictures were taken with
Leica DMi8 microscope and HAMAMTSU C11440 digital camera.
BMP treatment on zebrafish and chicken embryos. Zebrafish embryos were
collected and dechorionated at around 4-somite stage and treated with 200 μg/ml
Table 1 Antibodies
Antibody Concentration Species and type Provider (Cat #)
Prrx1 (for ChIP) 1:200 Rabbit polyclonal Sigma (HPA051084)
IgG 1:1000 Rabbit Diagenode (C15410206)
Myc tag 1:500 Goat pAb Abcam (ab9132)
Prrx1 (for IF) 1:100 Tanaka lab12
Snail1 (for IF in embryos and western blot) 1:50 Rabbit monoclonal Cell Signaling (C15D3, #3879)
GFP 1:500 Chicken polyclonal Aveslab (2BScientific, GFP-1020)
DIG-AP 1:1000 Fab fragments, sheep polyclonal Roche (11093274910)
DIG-POD 1:500 Fab fragments, sheep polyclonal Roche (11207733910)
FLUO-POD 1:500 Fab fragments, sheep polyclonal Roche (11426346910)
β-actin 1:2000 Rabbit polyclonal Abcam (ab8227)
Alexa Fluor 488 1:500 Goat anti-rabbit Invitrogen (A11008)
Alexa Fluor 568 1:500 Goat anti-rabbit Invitrogen (A11011)
Alexa Fluor 488 1:500 Goat anti-chicken Life technologies (A11039)
Alexa Fluor 568 1:500 Goat anti-rat Invitrogen (A11077)
Snail1 (for IF in cells) 1:50 Rat monoclonal Cell signaling (SN9H2, #4719)
Histone H3 1:500 Rabbit polyclonal Abcam (ab1791)
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of Human recombinant BMP4 protein (R&D Systems) which was added to
the water, and kept at 25 °C. Embryos were collected after 30 min or 12 h and
subjected to RNA extraction –qPCR. Collected embryos at different time points
were subjected to ISH and IF for SNAIL1 and PRRX1. Chicken embryos were
collected and cultured for 30 min prior BMP-soaked bead implantation. Human
recombinant BMP2 protein (R&D Systems) was loaded onto heparin acrylic
beads at a concentration of 0.2 mg/ml by soaking for 3 h at room temperature, and
they were introduced into one half of the lateral plate mesoderm of chick
embryos, close to the developing somites, at stage HH7, which were harvested at
different time points (between 30 min to 10 h). Beads loaded with PBS were used as
controls.
Western blot. E11.5 mouse embryos were dissected and lysed directly in RIPA
buffer (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% NP40, 1% sodium deox-
ycholate, 1% SDS and Proteinase inhibitor cocktail). Homozygous LacZ-Knock-in
Prrx1 mutant embryos were identified among littermates by PCR genotyping and
used for further analyses, together with wild-type embryos. Lysates were then
homogenized followed by heating, sonication (6 rounds of 15 min, 30 s ON/30 s
OFF, high). Samples were then loaded and subjected Coomassie Blue staining to
determine the quality and concentration of the samples. Next, protein samples
were loaded and migrated in 12% acrylamide gel and then transferred to PVDF
western blotting membrane (Roche). The membranes were blocked with 10% milk
and incubated with anti-Snail1 antibody overnight. Information and dilution for
antibodies are listed in Table 1. The next day, membranes were extensively washed
and incubated with secondary Peroxidase goat anti-Rabbit antibody, washed and
developed using Chemiluminescent HRP Substrate (ImmobilonTM Western,
Millipore). Pictures were obtained using Amersham Imager 680 (GE Healthcare).
β-actin (Rabbit polyclonal, Abcam) was used as housekeeping protein for nor-
malization. The uncropped and unprocessed scans of the blot are supplied in
Supplementary Fig. 9.
In silico analyses. Single-cell RNA-seq public data: Processed datasets of publicly
available data for single-cell RNA-seq were downloaded from NCBI Gene
Expression Omnibus (GEO) database (https://www.ncbi.nlm.nih.gov/geo/). Data
included single-cell RNA-seq from developing zebrafish and mouse embryos and
different cancer types (Supplementary Table 1). Among analyzed single cells, the
ones with no value for both Snail1 and Prrx1 were excluded. Hierarchical clustering
was performed using GENE-E (version 3.0.215, Broad Institute, Inc.). Values were
subjected to correlation analyses using Prism (GraphPad Softwares, Version 6.01,
2012) calculated based on Spearman r.
Metanalysis of oncogenomic data from breast cancer patients. To assess the
putative correlations between the expression of SNAIL1, PRRX1 and mature miR-
15 family members with OS in all subtypes (n= 1403), lymph-node positive
patients (n= 313) or basal subtype (n= 241), all available data sets (E-TABM-43,
GSE16716, GSE18728, GSE20194, GSE20271, GSE31448, GSE32646, GSE41998,
GSE6532, GSE20711, GSE7390, GSE21653, GSE31519, GSE5327, GSE17907, E-
MTAB-365, GSE37946, GSE2034, GSE2990, GSE17705, GSE1456, GSE12093,
GSE9195, GSE45255, GSE20685, GSE12276, GSE2603, GSE16391, GSE42568,
GSE11121, GSE3494, GSE16446, GSE4611, GSE26971, and GSE19615) were ana-
lyzed. Kaplan–Meier plots were generated using http://kmplot.com37,68. The
patient samples were grouped as either high or low for the expression of the genes
of interest, and the auto-select best cut-off was chosen for computation over the
entire data set.
Statistical and data analysis. Images were prepared using Adobe Photoshop and
Adobe Illustrator CS6. Sample size was estimated using GPower 3.1, and values
were set at p= 0.05 and beta= 0.8. All statistical analyses were performed using
Microsoft Excel 2013 and Prism (GraphPad Softwares, Version 6.01, 2012). For
reporter assays and qRT–PCR experiments, the corresponding treatments were
compared with controls using Student’s two-tailored t test or One-way ANOVA
with Bonferroni’s multiple comparison test. Spearman r was used for correlation
test of single-cell RNA-seq data. All bar graphs represent mean+ SEM (Standard
Error of the Mean). Statistical significances were as follows: *P ≤ 0.05, **P ≤ 0.01
and ***P ≤ 0.001.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The microarray data generated in this study, as well as public scRNA-seq data datasets
analyzed during the current study are available in the Gene Expression Omnibus (GEO)
repository under the following accession numbers that are also listed in Supplementary
Table 1. Microarray in MDA231 cells: GSE138078, Zebrafish embryos: GSM3067194,
mouse embryo: GSE87038, head and neck cancer patients: GSE103322, and breast cancer
patients: GSE75688. The source data underlying Fig. 1c, f–h, 2a–f, 3b–f, 4a–e and h, and
6a, and Supplementary Figs. 1f, g, 2a–f, 3a and c–i, 4a and g–j, 5c and e, and 7b are
provided as a Source Data file.
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